Anti-VTN antibody

Cat.#: 175040

Size:

Special Price 241.9 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Anti-VTN antibody
  • Documents
  • Description
    Mouse monoclonal antibody to VTN
  • Tested applications
    WB, IHC-P, FC
  • Species reactivity
    Human
  • Alternative names
    VN antibody; V75 antibody; VNT antibody
  • Isotype
    Mouse IgG2b
  • Preparation
    This antigen of this antibody was recombinant protein
  • Clonality
    Monoclonal
  • Formulation
    Liquid, 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
  • Storage instructions
    Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
  • Applications

    WB: 1:500-1:2,000

    IHC-P: 1:50-1:200

    FC: 1:50-1:100

  • Validations

    Fig1: Western blot analysis of VTN on human VTN recombinant protein using anti-VTN antibody at 1/1,000 dilution.

    Fig1: Western blot analysis of VTN on human VTN recombinant protein using anti-VTN antibody at 1/1,000 dilution.

    Fig2: Western blot analysis of VTN on HEK293 (1) and VTN-hIgGFc transfected HEK293 (2) cell lysate using anti-VTN antibody at 1/1,000 dilution.

    Fig2: Western blot analysis of VTN on HEK293 (1) and VTN-hIgGFc transfected HEK293 (2) cell lysate using anti-VTN antibody at 1/1,000 dilution.

    Fig3: Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue using anti-VTN antibody. Counter stained with hematoxylin.

    Fig3: Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue using anti-VTN antibody. Counter stained with hematoxylin.

    Fig4: Immunohistochemical analysis of paraffin-embedded human liver cancer tissue using anti-VTN antibody. Counter stained with hematoxylin.

    Fig4: Immunohistochemical analysis of paraffin-embedded human liver cancer tissue using anti-VTN antibody. Counter stained with hematoxylin.

    Fig5: Flow cytometric analysis of Hela cells with VTN antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).

    Fig5: Flow cytometric analysis of Hela cells with VTN antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).

  • Background
  • References
    • Yal nda A et al. Serum vitronectin levels in patients with Beh et's disease. Inflamm Res 61(11):1241-6 (2012).
    • Kadowaki M et al. Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach. J Cancer Res Clin Oncol 137(7):1105-15 (2011).

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"